Werbung
Werbung

RVPH

RVPH logo

Reviva Pharmaceuticals Holdings, Inc. Common Stock

0.37
USD
Gesponsert
+0.01
+1.37%
09. Jan., 12:45 UTC -5
Offen

RVPH Ergebnisberichte

Positives Überraschungsverhältnis

RVPH übertreffen die 13 der letzten 18Schätzungen.

72%

Nächster Bericht

Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.08
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+33.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-46.67%

Reviva Pharmaceuticals Holdings, Inc. Common Stock earnings per share and revenue

On 13. Nov. 2025, RVPH reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 39.46% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an increase of 33.33% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26. Dez. 2025 For Q4 25
Estimate
-$0.49
Aktuell
-
Überraschung
-
FAQ
For Q3 2025, Reviva Pharmaceuticals Holdings, Inc. Common Stock reported EPS of -$0.06, beating estimates by 39.46%, and revenue of $0.00, 0% as expectations.
The stock price moved down -7.19%, changed from $0.54 before the earnings release to $0.50 the day after.
The next earning report is scheduled for 30. März 2026.
Based on 10 analysts, Reviva Pharmaceuticals Holdings, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung